Pricing Log in Create free account
Saturday 17 October 2026 Export NUTX’s income statement to Excel — free account

Nutex Health Inc.

NUTX Healthcare Medical Care Facilities

Nutex Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $875.3 million, up 82.4% from fiscal 2024. In the quarter to June 2026, revenue fell 13.6%, EPS grew 424.8%, free cash flow grew 19.4% and total debt fell 1.69%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

185.95 14.85 −7.40%
Market cap
$1.4B
P/E
7.1×
Fwd P/E
6.3×
Dividend yield
—
F-score
7/9
Altman Z
3.27
Beneish M
−2.54
Dividend safety
41/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.15
Total sells 0.04
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy 1 — — — 4 — — — — — — —
Sell — — — — — — — — — — 1 —
Insider Ownership 33.05%

Capital & Financial Ratios $m

Market Cap 1,380.00
Revenue 846.72
Net Income 272.49
Free Cash Flow 274.17
Net Debt 93.00
Current Ratio 5.00 (at or above 1.5: strong)
Debt/Equity 0.59
P/E ratio 7.14
Fwd P/E 6.25
P/S ratio 1.51
P/B ratio 2.52
Past 5Y EPS Growth (22.22%) (below 0%: weak)
This Y EPS Growth 165.21% (at or above 15%: strong)
Next Y EPS Growth 0.28%
Next Y revenue growth (0.37%) (below 0%: weak)
Next 5Y EPS Growth 34.22% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.6×, against a ten-year median of 1.3×; over the ten years it ranged from 0.8× in 2025 to 14.5× in 2022.
P/S against its own 10 years 69.89%
10-year low 10-year high
P/B against its own 10 years 62.51%
10-year low 10-year high
EV/Sales against its own 10 years 55.66%
10-year low 10-year high
EV/FCF against its own 10 years 17.25%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 22 44 186 207
Receivables 63 236 325 357
Inventory 3 3 3 4
Other — — — —
91 292 539 586
2023 2024 2025 Q'26
Payables 25 10 49 10
ST’ Debt 14 18 14 0
Other — — — —
58 154 158 117

Compound Annual Growth %

10y 5y 3y
Sales — 26.14% 58.62%
Cash Flow — 23.41% 69.88%
Earnings — (7.75%) 0.00%
Book Value — 0.00% 52.10%

Revenue $m

Mar Jun Sep Dec Year
’26 216 211 — — —
’25 212 244 268 152 875
’24 67 76 79 258 480
’23 56 59 63 70 248
’22 79 58 28 54 219
’21 2 63 118 149 332
’20 0 0 0 273 274
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 76 34 — — —
’25 51 27 100 70 248
’24 3 13 7 0 23
’23 1 0 2 (2) 1
’22 36 18 (7) 5 51
’21 (1) 103 24 46 173
’20 (1) 0 0 88 87
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 74 32 — — —
’25 51 27 99 69 246
’24 2 13 6 0 21
’23 (3) (3) (1) (1) (8)
’22 27 10 (13) 12 36
’21 (1) 82 21 35 137
’20 (1) 0 0 27 25
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 6.52 9.58 — — —
’25 2.56 (2.95) 7.76 1.61 10.48
’24 (0.10) (0.07) (1.72) 11.12 9.71
’23 (1.50) (0.97) (1.50) (7.50) (10.49)
’22 6.28 (4.50) (97.45) (3.00) (100.45)
’21 (36.20) 7.51 18.84 52.48 42.62
’20 (35.98) 7.33 50.83 14.86 36.81
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — — 75.00 25.50 4.16 28.82

Analyst estimates 2026–2028

Powerpack
High — — — — — — 7,920.00 318.00 41.44 193.07
People
People Employees 18 6 6 12 14 24 1,150 800 800 944
Revenue/emp, $m 0.00 0.00 0.23 0.11 19.57 13.81 0.19 0.31 0.60 0.93
Income, $m
Income, $m Revenue — 0 1 1 274 332 219 248 480 875
Gross margin, % — (31.47) 62.87 39.23 57.51 54.08 7.03 14.04 40.89 50.76
EBT 0 (6) (1) (7) 146 169 (420) (48) 110 245
EBT margin, % 0.00 (25,894.40) (69.50) (520.82) 53.18 51.12 (191.36) (19.58) 22.88 27.97
Net income (7) 1 (1) (7) 146 169 (433) (43) 95 180
Depreciation 0 1 0 0 6 8 13 18 19 21
Per share, $
Per share, $ Revenue 0.00 21.09 119.91 56.46 69.31 83.85 51.81 56.18 94.28 137.59
Earnings (14,038.98) 364.70 (83.67) (230.61) (179.63) (48.94) (100.45) (10.49) 10.25 11.13
Cash flow (548.40) (649.64) (42.11) (166.97) 21.92 43.86 11.96 0.29 4.55 39.00
Capex 0.00 0.00 0.00 (3.47) (15.48) (9.34) (3.46) (2.15) (0.45) (0.40)
Free cash flow (548.40) (649.64) (42.11) (170.44) 6.45 34.52 8.50 (1.87) 4.10 38.61
Book value (11,738.80) 2,153.64 (131.35) 76.79 (0.29) 48.45 28.43 17.94 37.03 66.56
Shares, m 0 0 0 0 4 4 4 4 5 6
Valuation, ×
Valuation, × P/E — 70.50 70.50 70.50 70.50 70.50 0.00 0.00 3.19 17.38
P/S — 58.05 58.05 58.05 58.05 58.05 5.76 0.53 0.34 1.20
P/B — 328.93 328.93 328.93 328.93 328.93 10.50 1.67 0.86 2.47
EV/Sales — 58.03 58.03 58.03 58.03 58.03 6.71 1.47 0.87 1.33
EV/FCF — 144.40 144.40 144.40 144.40 144.40 40.89 (44.25) 20.03 4.72
Cash, $m
Cash, $m Operating cash flow 0 (1) 0 (4) 87 173 51 1 23 248
Capex — — — 0 (61) (37) (15) (9) (2) (3)
Free cash flow 0 (1) 0 (4) 25 137 36 (8) 21 246
Balance, $m
Balance, $m Working capital (6) (1) (1) (3) (1) 116 43 33 138 381
Total debt 0 0 1 2 0 155 242 254 300 312
Net debt 0 0 1 1 0 119 208 232 256 126
Shareholders’ equity (6) 2 (1) 2 (1) 192 120 79 189 423
Returns, %
Returns, % ROA (2,910.02) 30.32 (50.29) (199.29) 3,088.42 67.17 (102.80) (11.03) 9.89 9.00
ROIC 0.00 (132.11) 0.00 (137.79) 0.00 34.30 (77.50) (6.38) 18.36 31.34
ROE 0.00 (33.26) (218.01) (3,942.66) 29,249.21 139.24 (272.38) (45.92) 38.93 23.13
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Nutex Health Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ARDT Ardent Health, Inc. $1.7B 21.7× 7.7× −1.40% (below 0%: shrinking) −76.92% (below 0%: shrinking) +121.70% (above 0%: growing) 100.00% 3.44% Compare
CMPS COMPASS Pathways PLC Sponsored ADR $1.6B — (loss-making) — — n/m −4.18% (below 0%: shrinking) — 0.00% Compare
AMN AMN Healthcare Services Inc $1.6B 15.0× 31.2× +2.29% (above 0%: growing) n/m −389.43% (below 0%: shrinking) 30.58% 4.00% Compare
AGL Agilon Health, Inc. $1.5B — (loss-making) — (loss-making) +7.15% (above 0%: growing) n/m −50.19% (below 0%: shrinking) 7.17% 0.79% Compare
PNTG The Pennant Group, Inc. $1.5B 44.5× 26.9× +35.76% (above 0%: growing) +23.81% (above 0%: growing) −50.94% (below 0%: shrinking) 14.07% 5.77% Compare
HCSG Healthcare Services Group, Inc. $1.5B 12.2× 19.2× +2.69% (above 0%: growing) n/m −26.02% (below 0%: shrinking) 15.89% 4.72% Compare
NUTX Nutex Health Inc. $1.4B 7.1× 6.3× −13.62% (below 0%: shrinking) n/m +19.44% (above 0%: growing) 67.04% 57.75%
USPH U.S. Physical Therapy, Inc. $1.3B 504× 27.7× +8.47% (above 0%: growing) −56.90% (below 0%: shrinking) −8.24% (below 0%: shrinking) 19.59% 10.25% Compare
INNV InnovAge Holding Corp. $1.2B — (loss-making) 17.2× +18.31% (above 0%: growing) n/m +85.44% (above 0%: growing) 23.88% 3.87% Compare
Median of peers $1.5B 21.7× 23.0× +7.15% −56.90% −17.13% 19.59% 3.93%

All 55 Medical Care Facilities stocks →

Nutex Health Inc. (NUTX) key facts

  • Strength: Nutex Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $875.3 million, up 82.4% from fiscal 2024.
  • Nutex Health Inc. (NUTX) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, NUTX traded at $185.95, a market capitalization of $1.4 billion.
  • Return on equity was 23.1% and debt-to-equity 0.59.
  • Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 3.27 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Nutex Health Inc. (NUTX) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/NUTX · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com